XXA1_Y4eK-BH3
General Information
DCTPep ID DCTPep03032
Peptide Name XXA1_Y4eK-BH3
Sequence RPEIWYAQGLKRFGDEFNAYKAR
Sequence Length 23
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide Cancer targeted peptides Induce apoptosis Bcl-xL inhibitors BH3 peptides and mimetics
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
MDA-MB-231 (Bc1-xL dependent) | Breast adenocarcinoma | EC50=82 ± 27 nM | Not available | Not available | 1 |
OCI-Ly1 (Bcl-2 dependent) | Diffuse large B-cell lymphoma | EC50=911 ± 222 nM | Not available | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Bcl-xL
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep03032
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C130H191N37O34
Absent amino acids CHMSTV
Theoretical pI 9.52
Acidic residues 3
Basic residues 5
Polar residues 5
Molecular weight (Average) 2816.17
Molecular weight (Monoisotopic) 2814.44
Common amino acids AR
Net charge 2
Instability index (II) 54.65
Aliphatic index 46.96
Grand average of hydropathicity (GRAVY) -1.104
Half Life
1 hours (mammalian reticulocytes, in vitro).
2 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 8480
Abs 0.1% (=1 g/l) 3.011
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 25451027
Title Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL
Year 2015
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available